A carregar...
Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis
Ulcerative colitis is a chronic, idiopathic, inflammatory bowel disease characterized by a relapsing and remitting course. A substantial proportion of patients fail conventional therapies despite therapy with immunosuppressives and tumor necrosis factor antagonists. Accordingly, newer therapeutic ag...
Na minha lista:
| Publicado no: | Pharmacotherapy |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709861/ https://ncbi.nlm.nih.gov/pubmed/25884529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1561 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|